John Paulson should subscribe to the Junkie...

I wonder if John Paulson subscribed to the ETF Junkie letter he wouldn't have lost 26 billion dollars so far this year on his drug stock positions.  Meanwhile, the Junkies are currently up 75% on their inverse biotech trade over the last 6 weeks.

If you don't already receive the ETF Junkie letter, it's still free to subscribe at ETFJunkie.com.